The rHEALTH analyzer is a miniature flow cytometer for biomarker identification to assess biological changes in space, as well as a medical analyzer, which is designed for diagnosing/monitoring spaceflight medical conditions such as blood clots, kidney stones, radiation exposure, and other illnesses and injuries.
The experiment was conducted across two sessions wherein the crewmember used 4 different types of ‘control samples’ to demonstrate the functionality of the rHEALTH in microgravity. The rHEALTH analyzer was developed in part with NASA sponsorship via the Human Research Program (HRP) and the Small Business Innovative Research (SBIR) program over the past several years.
This modified commercial-off-the-shelf hardware was developed for flight and operated by ZIN Technologies, under direction of HRP’s Exploration Medical Capability (ExMC) element at Glenn Research Center (GRC) with support from the Johnson Space Center (JSC) Immunology Laboratory. Payload integration was performed by the Research Operations and Integration (ROI) element of HRP at JSC. ZIN Technologies was acquired by Voyager Space in March 2023.
